GROUPAMA ASSET MANAGMENT

Position in JNJ — Johnson & Johnson

CIK 1055969 PARIS, I0

Position in JNJ

as of Mar 31, 2026 · filed May 22, 2026 Compact

Position Value

$5,547,076

-$1,444,522 QoQ

Shares Held

22,693

-32.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GROUPAMA ASSET MANAGMENT holds $418,001,230 across 10 Drug Manufacturers - General names. JNJ ranks #5 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	863,629	$170,324,911
2	MRK	Merck & Co., Inc.	874,963	$105,249,299
3	LLY	ELI LILLY & Co	95,376	$87,723,983
4	ABBV	AbbVie Inc.	156,150	$33,961,063
5	JNJ	Johnson & Johnson This page	22,693	$5,547,076
6	GILD	Gilead Sciences, Inc.	37,990	$5,294,666
7	AMGN	Amgen Inc	14,960	$5,263,676
8	PFE	Pfizer Inc	63,889	$1,794,003

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,547,076	22,693	-32.8%	Shares	Sole	2026-05-22
2025-12-31	$6,991,598	33,784	-8.0%	Shares	Sole	2026-02-27
2025-09-30	$6,808,436	36,719	-6.4%	Shares	Sole	2025-12-01
2025-06-30	$5,989,938	39,214	+13.9%	Shares	Sole	2025-08-13
2025-03-31	$5,711,032	34,437	-17.8%	Shares	Sole	2025-05-14
2024-12-31	$6,058,421	41,892	-18.6%	Shares	Sole	2025-02-12
2024-09-30	$8,335,393	51,434	-9.5%	Shares	Sole	2024-11-15
2024-06-30	$8,309,780	56,854	+73.1%	Shares	Sole	2024-08-14
2024-03-31	$5,196,857	32,852	+5131.2%	Shares	Sole	2024-05-14
2023-12-31	$98,432	628	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.